saRNA Injection Targets Cardiac Injury
Preclinical study shows saRNA therapy improved cardiac function and reduced infarct size after myocardial infarction
False
Preclinical study shows saRNA therapy improved cardiac function and reduced infarct size after myocardial infarction
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
September 30, 2026
10 min read
How direct T-cell reprogramming could simplify CAR-T manufacturing, expand patient access, and extend cellular immunotherapy to new indications
September 29, 2026
5 min read
Coordinated development and practical testing pathways can help ensure eligible patients are identified from the point of approval
September 28, 2026
3 min read
Phase I study will test whether a targeted lentiviral vector can generate BCMA-directed CAR T cells inside patients with multiple myeloma
September 28, 2026
2 min read
Renee Aguiar-Lucander argues that faster clinical trials and more pragmatic regulation are essential to bringing medicines to patients sooner
False
Affiliations:
Specialties:
Areas of Expertise: